Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc. (CRDL) has generated zero cyber incidents and zero red-flag 8-K filings in our 90-day monitoring window, suggesting operational stability over the near term. However, low signal in a short window does not indicate low structural risk; the company's capital structure, equity dilution trajectory, and financing history may reveal material vulnerabilities. The full $49 Report expands to 12 months of 8-K context, calculates dilution risk scores, maps financing rounds, and applies AI risk signals across governance and disclosure patterns. The full $49 Report adds quantified dilution risk, 12-month 8-K timeline, and AI-scored governance health metrics.